This fund supports the education and research activities of the Alumni.

The fund supports the Centre of Regulatory Excellence (CoRE) in their education programmes.

The Centre of Regulatory Excellence (CoRE) was established in 2014 at the Duke-NUS Medical School in Singapore to support strengthening of health product regulatory systems in the Asia Pacific region, with a special focus on South-East Asia. Guided by its mission, CoRE contributes to improving patient access to health products, and enhancing regional health systems and health security. The Centre is gaining increasing recognition as a neutral, academic convener of dialogues, seminars and round tables involving international thought leaders in health regulation and healthcare systems.

Professor Sir Alasdair Breckenridge was a highly respected educator and globally acclaimed clinical pharmacologist, international scientist, and visionary regulatory professional during his lifetime. He was associated with many scientific, academic and policy achievements around the world, and one of these was his close association with Singapore and the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS).

To honour his memory and continue his mission, the Alasdair Breckenridge Fund is established to further regulatory capacity building through study awards tenable at CoRE.

This fund will continue to promote sustained and meaningful professional capacity development, and broaden access to learning opportunities across the region. This study award will support and finance healthcare professionals from National Regulatory Authorities, Ministries of Health, and related organisations from ASEAN and Asia-Pacific to enrol in courses run by CoRE. This will enhance their professional development and strengthen the regulatory capacity of their organisations. The fund will offset participants’ course fees, travel expenses and accommodation.